Mostaza JM - Search Results

1

Carotid atherosclerosis severity in relation to glycemic status: a cross-sectional population study.

Mostaza JM, Lahoz C, Salinero-Fort MA, de Burgos-Lunar C, Laguna F, Estirado E, García-Iglesias F, González-Alegre T, Cornejo-Del-Río V, Sabín C, López S; SPREDIA-2 Group. Mostaza JM, et al. Atherosclerosis. 2015 Oct;242(2):377-82. doi: 10.1016/j.atherosclerosis.2015.07.028. Epub 2015 Jul 15. Atherosclerosis. 2015. PMID: 26275375

2

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.

Lahoz C, Peña R, Mostaza JM, Jiménez J, Subirats E, Pintó X, Taboada M, López-Pastor A; RAP Study Group. Lahoz C, et al. Among authors: mostaza jm. Atherosclerosis. 2003 Jun;168(2):289-95. doi: 10.1016/s0021-9150(03)00094-7. Atherosclerosis. 2003. PMID: 12801612

3

[Ankle brachial index and cardiovascular risk].

Mostaza JM, Vicente I, Cairols M, Castillo J, González-Juanatey JR, Pomar JL, Lahoz C. Mostaza JM, et al. Med Clin (Barc). 2003 Jun 14;121(2):68-73. doi: 10.1016/s0025-7753(03)73857-3. Med Clin (Barc). 2003. PMID: 12828888 Review. Spanish. No abstract available.

4

C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia.

Mostaza JM, Camino N, Gerique JG, Peña R, Baquero M, Lahoz C. Mostaza JM, et al. Metabolism. 2005 Jan;54(1):33-7. doi: 10.1016/j.metabol.2004.07.009. Metabolism. 2005. PMID: 15562377

5

[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function].

Mostaza JM, Vicente I, Taboada M, Laguna F, Echániz A, García-Iglesias F, Lahoz C. Mostaza JM, et al. Med Clin (Barc). 2005 Apr 9;124(13):487-90. doi: 10.1157/13073561. Med Clin (Barc). 2005. PMID: 15847765 Spanish.

6

Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment.

Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X. Lahoz C, et al. Among authors: mostaza jm. Metabolism. 2005 Jun;54(6):741-7. doi: 10.1016/j.metabol.2004.12.020. Metabolism. 2005. PMID: 15931608 Clinical Trial.

7

The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment.

Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X; RAP Study Group. Lahoz C, et al. Among authors: mostaza jm. Atherosclerosis. 2005 Sep;182(1):129-34. doi: 10.1016/j.atherosclerosis.2005.02.001. Epub 2005 Feb 26. Atherosclerosis. 2005. PMID: 16115483 Clinical Trial.

8

Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age.

Lahoz C, Vicente I, Laguna F, García-Iglesias MF, Taboada M, Mostaza JM. Lahoz C, et al. Among authors: mostaza jm. Diabetes Care. 2006 Jan;29(1):148-50. doi: 10.2337/diacare.29.1.148. Diabetes Care. 2006. PMID: 16373915 No abstract available.

9

[Risk score for diabetic patients. Is really necessary?].

Mostaza JM, Lahoz C. Mostaza JM, et al. Med Clin (Barc). 2006 Apr 8;126(13):495-6. doi: 10.1157/13086851. Med Clin (Barc). 2006. PMID: 16624229 Spanish. No abstract available.

10

[Tables for cardiovascular risk estimation: many questions remain].

Mostaza JM, Lahoz C. Mostaza JM, et al. Med Clin (Barc). 2006 Apr 15;126(14):535-6. doi: 10.1157/13087151. Med Clin (Barc). 2006. PMID: 16756905 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page